Avid Bioservices Inc (CDMO)

[freethemice]

I think it comes down to how the enrollment proceeded in both trials.
The second-line NSCLC trial took 16 months (June 4, 2010 - Oct 6, 2011) to enroll 121 patients.
The pancreatic trial took 17.5 months (Jan 5, 2011 - June 25, 2012) to enroll 70 patients.
At the time the data was reported for the second-line NSCLC trial the MOS of 13 months was only
2 months more than the time since enrollment closed. If the pancreatic trial took about 3 months to enroll
the last 10% of the patients I can see how the MOS could be much longer than the time since the enrollment closed.